Genomic Health Reports Landmark TAILORx Results, Published in NEJM Demonstrate Oncotype DX Breast Recurrence Score Test Definitively Identifies 70% of Women with Early-stage Breast Cancer Who Receive No Benefit from Chemotherapy
Benzinga Newdesk